Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4370 results

Sort By:

Evaluation of C-arm PCD-CBCT for Image-Guided Interventions

Study ID: NCT07092553
Start Date: 2025-10
End Date: 2027-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

C-arm PCD-CBCT

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

Recovery-oriented Group Therapy for Veteran Men With Military Sexual Trauma

Study ID: NCT06741202
Start Date: 2025-10-20
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

32

Intervention / Treatment

Men's MST Group

Present-Centered Group Therapy

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

The Effect of Immersive Virtual Reality Treatment With Cognitive Behaviour Therapy for Obsessive-Compulsive Disorder

Study ID: NCT04534907
Start Date: 2025-12-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

The combination of exposure and response prevention (ERP) and VR

Traditional ERP

Sponsor

Shanghai Mental Health Center

Source: clinicaltrials.gov

Share:
Add to list

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

Study ID: NCT06303193
Start Date: 2025-10-01
End Date: 2035-01-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

160

Intervention / Treatment

pacritinib

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Study ID: NCT07193511
Start Date: 2025-10
End Date: 2030-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

355

Intervention / Treatment

AVZO-103

Combination Agent

Sponsor

Avenzo Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer

Study ID: NCT06991738
Start Date: 2025-10-01
End Date: 2032-08-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

18

Intervention / Treatment

68Ga-DOTA-TATE PET Scan

Amino acid infusions

177Lu-DOTA-EB-TATE

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Source: clinicaltrials.gov

Share:
Add to list

Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer

Study ID: NCT06856499
Start Date: 2025-12
End Date: 2029-07
Study Type

Interventional

Study Phase

Phase1

No. of Participants

50

Intervention / Treatment

Cirtuvivint

Flapberry

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

Effectiveness of Bupivacaine, Ketorolac, Ketamine, vs Bupivacaine Alone in Reducing Postoperative Pocket Pain

Study ID: NCT05575999
Start Date: 2026-01
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

200

Intervention / Treatment

Bupivacaine alone OR Bupivacaine-Ketorolac-Ketamine (BKK) Combination

Sponsor

Kansas City Heart Rhythm Research Foundation

Source: clinicaltrials.gov

Share:
Add to list

Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

Study ID: NCT07174349
Start Date: 2025-10-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

20

Intervention / Treatment

Uroselective alpha-1-adrenergic receptor antagonist

Placebo

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

EMMVIES : Walking Training at Home in VIrtual Reality for Children With Chronic Illnesses Impacting Physical Health

Study ID: NCT07021638
Start Date: 2025-10-01
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

EMMVIES program

Sponsor

University Hospital, Angers

Source: clinicaltrials.gov

Share:
Add to list